Related Experiment Video
Updated: Jun 15, 2026

Listeria monocytogenes Infection of the Brain
Published on: October 2, 2018
Listeria monocytogenes infection in patients with systemic lupus erythematosus
Gabriel J Tobón1, Mario J Serna, Carlos A Cañas
1Rheumatology Unit, Fundación Clínica Valle del Lili, Cra. 98 18-49, Cali, Colombia, South America.
Abstract:
Listeria monocytogenes infection (LMI) is a rare complication in systemic lupus erythematosus (SLE) patients, and it is associated with nonspecific clinical manifestations and is often mistaken with SLE flares. Several cases of LMI in SLE patients have been reported, with high mortality rates. This article describes five new cases of LMI in patient with SLE in a cohort of 174 patients (2.8%). All patients were women, with a mean age of 19.4 years (range, 5-29 years). Mean duration of SLE before clinical LMI was 2.8 years (range, 2-4 years). Recurrent infection was not evidenced. At the time of LMI, all patients had an inactive disease, receiving steroids and immunosuppressive treatment. Clinical picture of meningitis was present in two patients. All patients were treated with ampicillin, with resolution of clinical manifestations without sequels. In order to eliminate the intracellular forms of L. monocytogenes, trimethoprim-sulfamethoxazole was initiated, and an allergic skin reaction was presented in all but one patient. Our report highlights the unspecific clinical manifestations of LMI and these characteristics are initially challenging and may be interpreted as lupus flares. An accurate diagnosis and an early antibiotic treatment are essential to improve the outcome in these patients.
Insights
Listeria monocytogenes infection (LMI) is a rare but serious complication in patients with systemic lupus erythematosus (SLE). Early diagnosis and antibiotic treatment are crucial for improving outcomes in these vulnerable patients.
Area of Science:
- Infectious Diseases
- Rheumatology
- Clinical Medicine
Background:
- Systemic lupus erythematosus (SLE) patients are susceptible to infections due to immunosuppressive therapy.
- Listeria monocytogenes infection (LMI) is a rare but severe complication in SLE patients.
- LMI often presents with nonspecific symptoms, mimicking SLE flares.
Observation:
- Five new cases of LMI in SLE patients (2.8% of 174) were identified.
- All affected patients were young women with inactive SLE, on immunosuppressive treatment.
- Clinical presentations included meningitis in two patients.
Findings:
- Ampicillin treatment led to clinical resolution without sequelae.
- Trimethoprim-sulfamethoxazole was used for intracellular L. monocytogenes, causing allergic reactions in most patients.
- LMI manifestations are nonspecific and can be mistaken for SLE flares.
Implications:
- Accurate and timely diagnosis of LMI in SLE patients is critical.
- Early antibiotic intervention is essential for improving patient outcomes.
- Increased awareness of LMI is needed in SLE management.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Cryptococcal Meningitis
Nephrotic Syndrome III : Nursing Management
Nephrotic Syndrome II : Assessment and Medical Management
Rocky Mountain Spotted Fever

